The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Alzheimer's drugs in developmen as of February 2019, by clinical trial phase
Alzheimer's drugs in development in 2019, by clinical trial phase
As of February 2019, over half of the 132 drugs in development for Alzheimer's disease were in the second clinical trial phase. This statistic depicts the amount of Alzheimer's drugs in development as of February 2019, by clinical trial phase.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Phase 3 Alzheimer's drugs in development July 2019, by mechanism of action
- Basic Statistic Pharmaceutical companies with Alzheimer's drugs in development 2019
- Premium Statistic Prescription spending per capita for 65+ year-olds in U.S. by insurance 2010-2020
- Basic Statistic Number of new medicines in R&D pipeline worldwide 2021-2023, by phase
- Basic Statistic Clinical trial costs by select component and phase
- Premium Statistic Total R&D costs of select cancer drugs 2017
- Basic Statistic Phase 2 and 3 trials in Alzheimer’s drug development by region 2025
- Basic Statistic Total per-study costs by clinical trial phase and therapeutic area
- Basic Statistic Outlook for top narcolepsy products in the global market 2020-2026
- Premium Statistic Per day clinical trial mean direct cost by phase
About the region
10
- Basic Statistic Clinical trials initiated worldwide 2018-2024, by trial phase
- Basic Statistic 3 year average R&D cost to develop new biopharmaceutical compounds 2010-2020
- Basic Statistic R&D cost to develop new pharmaceutical compounds 2010-2020
- Basic Statistic Indication expansions and new products drug pipeline worldwide 2020
- Premium Statistic Global pharmaceutical R&D spending vs US and China 2014-2023
- Premium Statistic Clinical trials initiated worldwide 2018-2024
- Premium Statistic Percentage return on R&D among large cap biopharma companies 2010-2020
- Premium Statistic Share of active trials for Alzheimer's Disease pipeline 2022, by product type
- Premium Statistic Leading orphan drugs based on R&D phase III cost 2015
- Basic Statistic Market share of clinical trials worldwide by segment
Selected statistics
10
- Premium Statistic Clinical trial success rates by therapeutic area 2020
- Premium Statistic R&D expenditure of new therapeutic drugs 2009-2018
- Basic Statistic Estimated clinical trial cost per patient by therapeutic class 2015-2017
- Basic Statistic Estimated clinical trial cost per drug by therapeutic class 2015-2017
- Premium Statistic Time from R&D start to approval of select cancer drugs 2017
- Premium Statistic Total R&D costs including costs of capital for select cancer drugs 2017
- Premium Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2025-2030
- Premium Statistic Prescription spending per capita for U.S. under 26-agers by insurance 2010-2020
- Basic Statistic Number of registered clinical studies by location worldwide 2026
- Basic Statistic Leading orphan drugs in development based on net present value 2025
Other regions
10
- Premium Statistic U.S. pharmaceutical industry spending on research and development 1990-2024
- Premium Statistic U.S. pharma industry R&D expenditure 1980-2024
- Basic Statistic U.S. human and veterinary pharmaceuticals - R&D spending 2017
- Basic Statistic YTD stock performance of biopharma companies working on COVID March 2020
- Premium Statistic R&D expenditure in U.S. biotechnology 2009-2010 by type
- Premium Statistic Total prescription spending in the U.S. 2010-2020
- Basic Statistic U.S. venture investments in infectious disease companies 2006-2023
- Basic Statistic Top drug classes prescribed to seniors in Canada by rate of use 2021
- Basic Statistic U.S. consumer feelings about direct-to-consumer pharmaceutical ads in 2017
- Premium Statistic Physicians that received opioid-manufacturer payments in New York 2013-2015
Related statistics
10
- Basic Statistic Investments made by clinical research organizations by phase 2009-2014
- Basic Statistic Number of applications for clinical trials in Denmark 2013-2021, by sponsor
- Basic Statistic Retail price increase of geriatric drugs in the U.S. in 2020, by manufacturer
- Basic Statistic Biosimilars in development and approved by FDA 2019, by manufacturer
- Basic Statistic Active immuno-oncological agents in development U.S. 2019, by type
- Basic Statistic Alzheimer’s disease drugs in trial phase III by mechanism of action 2025
- Basic Statistic Cell and gene therapy clinical trials in development worldwide 2019, by trial phase
- Basic Statistic Alzheimer’s disease therapies in phase II development 2025, by type
- Basic Statistic Alzheimer’s disease drugs in trial phase II by mechanism of action 2025
- Basic Statistic Number of active trials in Alzheimer's Disease pipeline 2022, by product type
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
BioSpace. (September 23, 2019). Alzheimer's drugs in developmen as of February 2019, by clinical trial phase [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 25, 2026, from /statistics/1093301/alzheimers-drugs-in-development-by-trial-phase-us/
BioSpace. "Alzheimer's drugs in developmen as of February 2019, by clinical trial phase." Chart. September 23, 2019. ÌÇÐÄÆƽâ°æ. Accessed July 25, 2026. /statistics/1093301/alzheimers-drugs-in-development-by-trial-phase-us/
BioSpace. (2019). Alzheimer's drugs in developmen as of February 2019, by clinical trial phase. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 25, 2026. /statistics/1093301/alzheimers-drugs-in-development-by-trial-phase-us/
BioSpace. "Alzheimer's Drugs in Developmen as of February 2019, by Clinical Trial Phase." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 23 Sep 2019, /statistics/1093301/alzheimers-drugs-in-development-by-trial-phase-us/
BioSpace, Alzheimer's drugs in developmen as of February 2019, by clinical trial phase ÌÇÐÄÆƽâ°æ, /statistics/1093301/alzheimers-drugs-in-development-by-trial-phase-us/ (last visited July 25, 2026)
Alzheimer's drugs in developmen as of February 2019, by clinical trial phase [Graph], BioSpace, September 23, 2019. [Online]. Available: /statistics/1093301/alzheimers-drugs-in-development-by-trial-phase-us/
Advertisement